FGF7 protein expression in human breast carcinomas

Journal of Pathology

Volumn 186, Issue 3, 1998, Pages 269-274

  Jacquemier, Jocelyne ^a   Sun, Zhen Zhu ^a,c   Penault Llorca, Frédérique ^a,d   Geneix, Jeanine ^a   Devilard, Elizabeth ^a   Adélaïde, José ^a   Birnbaum, Daniel ^a,b  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

^c PEOPLE S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION   (China)

^d CENTRE JEAN PERRIN   (France)

Author keywords

Breast cancer; Cell cell communication; Expression; FGF7; Fibroblast growth factor; Growth factor; Keratinocyte growth factor; Mammary gland; Stroma; Tumourigenesis

Indexed keywords

FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY;

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TUMOR CELL;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHI-SQUARE DISTRIBUTION; FEMALE; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; SURVIVAL RATE;

EID: 0031786983     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(1998110)186:3<269::AID-PATH187>3.0.CO;2-G     Document Type: Article

References (44)

1. Coulier F, Pontarotti P, Roubin R, Hartung H, Goldfarb M, Birnbaum D. Of worms and men: an evolutionary perspective on the FGF and FGF receptor families. J Mol Evol 1997; 44: 43-56.
2. Goldfarb M. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 1996; 7: 311-325.
3. Johnson D, Williams L. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993; 60: 1-41.
4. Ornitz D, Xu J, Colvin J, et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996; 271: 15 292-15 297.
5. Cullen K, Yee D, Bates S, et al. Regulation of human breast cancer by secreted growth factors. Acta Oncol 1989; 28: 835-839.
6. Halaban R, Kwon S, Ghosh S, Delli Bovi P, Baird A. bFGF as an autocrine growth factor for human melanomas. Oncogene Res 1988; 3: 177-186.
7. Becker D, Lee P, Rodeck U, Herlyn M. Inhibition of the fibroblast growth factor receptor 1 gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 1992; 7: 2303-2313.
8. Saxena A, Ali IU. Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines. Oncogene 1992; 7: 243-247.
9. Kobrin M, Yamanaka M, Friess M, Lopez M, Korc M. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993; 53: 4741-4744.
10. Yamanaka Y, Friess H, Büchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumour stage. Cancer Res 1993; 53: 5289-5296.
11. Yan G, Fukabori Y, McBride G, Nikolaropolou S, McKeehan W. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 1993; 13: 4513-4522.
12. Leung H, Gullick W, Lemoine N. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 1994; 59: 667-675.
13. Morrison R, Yamaguchi F, Bruner J, Tang M, McKeehan W, Berger M. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 1994; 54: 2794-2799.
14. Yamaguchi F, Saya H, Bruner J, Morrison R. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 1994; 91: 484-488.
15. Ueki T, Koji T, Tamiya S, Nakane P, Tsuneyoshi M. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma. J Pathol 1995; 177: 353-361.
16. Myoken Y, Myoken Y, Okamoto T, et al. Expression of fibroblast growth factor (FGF-1). FGF-2 and FGF receptor-1 in a human salivary gland adenocarcinoma cell line: evidence for autocrine growth Int J Cancer 1996; 65: 650-657.
17. Itoh H, Hattori Y, Sakamoto H, et al. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity Cancer Res 1994; 54: 3237-3241.
18. Ishii H, Hattori Y, Itoh H, et al. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines. Cancer Res 1994; 54: 518-522.
19. Penault-Llorca F, Pare P, Coulier F, Bertucci F, Jacquemier J, Birnbaum D. Expression of variant forms of fibroblast growth factor receptor 2 mRNA in human breast carcinomas. Int J Oncol 1997; 10: 1191-1196.
20. Chaffanet M, Popovici C, Leroux D. et al. t(6;8), t(8;9) and t(8;13) translocation associated with myelodysplastic syndromes have close or identical breakpoints on chromosome 8p11-12. Ontogene 1998; 16: 945-949.
21. Chesi M, Nardini E, Brents L, el at. Frequent translocation t(1:14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genet 1997; 16: 260-264.
22. Muller W, Lee F, Dickson C, Peters G, Pattengale P, Leder P. The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J 1990; 9: 907-913.
23. Kitsberg D, Leder P. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene 1996; 13: 2507-2515.
24. Jacquemier J, Adélaïde J, Parc P, et al Expression of the FGFR1 gene in human breast-carcinoma cells. Int J Cancer 1994; 59: 373-378.
25. Penault-Llorca F, Bertucci F, Adélaïde J, et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 1995;61: 170-176.
26. Theillet C, Adélaïde J, Louason G, et al FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosom Cancer 1993; 7: 219-226.
27. Rapport des Anatomopathologistes du Groupe de Travail. Dépistage du cancer du sein de l'Union Européenne - recommandations européennes pour l'assurance de qualité dans le cadre du dépistage mammographique du cancer du sein. Ann Pathol 1996; 16: 315-333.
28. Jacquemier J, Moles JP, Penault-Llorca F, et al P53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: prognostic significance. Br J Cancer 1994; 69: 846-852.
29. Penault-Llorca F, Adélaïde J, Houvenaeghel G, Hassoun J, Birnbaum D, Jacquemier J. Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation. J Pathol 1994; 173: 65-75.
30. Koos R, Banks P, Inkster S, Yue W, Brodie A. Detection of aromatase and keratinocyte growth factor expression in breast tumours using reverse transcription-polymerase chain reaction. J Steroid Biochem Mulec Biol 1993; 45: 217-225.
31. Bansal GS, Cox HC, Marsh S, et al. Expression of keratinocyte growth factor and its receptor in human breast cancer. Br J Cancer 1997: 75: 1567-1574.
32. Imagawa W, Cunha G, Young P, Nandi S. Keratinocyte growth factor and acidic fibroblast growth factor are mitogens for primary cultures of mammary epithelium. Biochem Biophys Res Commun 1994; 204: 1165-1169.
33. Ulich TR, Yi E, Cardiff R, et al. Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. Am J Pathol 1994; 144: 862-868.
34. Yi E, Bedoya A, Lee H, et al. Keratinocyte growth factor causes cystic dilation of the mammary glands of mice. Am J Pathol 1994; 145: 1015-1022.
35. Luqmani YA, Bansal G, Mortimer C, Buluwela L, Coombes RC. Expression of FGFR2 BEK and K-SAM mRNA variants in normal and malignant human breast. Eur J Cancer 1996; 32A: 518-524.
36. McGarvey TW, Stearns ME, Keratinocyte growth factor and receptor mRNA expression in benign and malignant human prostate. Exp Mol Pathol 1995; 63: 52-62.
37. Siddiqi I, Funatomi H, Kobrin MS, Friess H, Buchler MW, Korc M. Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1995; 215: 309-315.
38. Janot F, El-Naggar AK, Morrison R, Liu TJ, Taylor D, Clayman G. Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 1995; 64: 117-123.
39. Bansal GS, Yiangou C, Coope RC, et al. Expression of fibroblast growth factor l is lower in breast cancer than in the normal human breast. Br J Cancer 1995; 72: 1420-1426.
40. Yiangou C, Gomm JJ, Coope RC, et al. Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance. Br J Cancer 1997; 15: 28-33.
41. Cullinan K, Koos R. Expression of basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and keratinocyte growth factor (KGF), in the rat uterus - stimulation by estrogen. Biol Reprod 1991; 44: 536.
42. Yan G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan W, Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 1992; 6: 2123-2128.
43. Finch P, Lengel C, Chedid M. Cloning and characterisation of the promoter region of the human keratinocyte growth factor gene. J Biol Chem 1995; 270: 11 230-11 237.
44. Ethier P. Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst 1995; 87: 964-973.